Is Ozempic the Same as Semaglutide? Brand Names vs the Molecule, Explained
Yes. Ozempic is Novo Nordisk's brand name for semaglutide. Wegovy, Rybelsus and India's generic pens like Semasize all contain the same molecule. Here is how the names map to each other, and what actually differs between them.
ALTRcare Medical Team
Clinical Editorial
Yes, Ozempic is semaglutide. Ozempic is not a different medicine; it is Novo Nordisk's brand name for the molecule semaglutide, sold as a once-weekly injection pen. The confusion is understandable because the same molecule is sold under several names: Ozempic (approved for type 2 diabetes), Wegovy (approved for weight management at higher doses), Rybelsus (the daily tablet form), and since March 2026, a wave of DCGI-approved Indian generics such as Alkem's Semasize. Every one of these contains semaglutide. What changes between them is the approved use, the dose range, the device, and the price.
Brand name vs generic name: how medicine naming works
Every medicine has two names. The generic name is the molecule itself: semaglutide. The brand name is what a company calls its version of that molecule: Ozempic, Wegovy, Semasize. It works exactly like paracetamol and Crocin. Crocin is a brand; paracetamol is the medicine inside it. Nobody asks whether Crocin is the same as paracetamol, but because Ozempic became famous first, many people think Ozempic is the medicine and semaglutide is something else. It is the other way around.
The full semaglutide family, mapped
| Name | Company | Form | Approved for | Available in India? |
|---|---|---|---|---|
| Ozempic | Novo Nordisk | Weekly injection pen (up to 2 mg) | Type 2 diabetes | Limited, imported |
| Wegovy | Novo Nordisk | Weekly injection pen (up to 2.4 mg) | Weight management | Yes, launched 2025 |
| Rybelsus | Novo Nordisk | Daily tablet | Type 2 diabetes | Yes |
| Semasize | Alkem | Weekly injection pen | Prescribed by doctors for metabolic care | Yes, from March 2026 |
| Other Indian generics | Dr. Reddy's, Cipla, Sun and others | Pens and vials | Varies by brand | Yes, from March 2026 |
So why do Ozempic and Wegovy exist separately?
Novo Nordisk ran separate clinical trial programs for diabetes and for weight management, and regulators approved the two uses under two brand names. Ozempic tops out at 2 mg weekly and carries the diabetes approval. Wegovy goes up to 2.4 mg weekly and carries the weight-management approval. The molecule in the pen is identical; the label, the maximum dose and the marketing are what differ. This is also why you may have heard of Ozempic being used off-label for weight loss in countries where Wegovy was not yet available.
What changed in India in March 2026
Semaglutide's Indian patent expired in March 2026. That opened the door for Indian pharmaceutical companies to launch their own semaglutide, and more than 40 generic versions were announced within months. The credible ones did not skip the science: CDSCO's Subsequent New Drug pathway required completed Phase 3 trials in Indian patients. Alkem's SIZE-DM trial, for example, randomized 320 patients between its semaglutide and the Novo Nordisk original and demonstrated non-inferiority. The practical result is that the same molecule that costs ₹5,660 to ₹16,400 a month as Wegovy is available from DCGI-approved Indian brands starting near ₹1,800 a month.
Same molecule does not mean buy it anywhere
Because semaglutide is now cheap and famous, fake pens and unregulated 'research grade' vials have flooded Telegram and Instagram. A genuine product comes from a licensed pharmacy against a doctor's prescription, with a batch number you can verify. If a seller does not ask for a prescription, walk away.
Which version should you actually take?
That is a decision for a doctor who has seen your history, your blood work and your goals, not a brand-loyalty question. For most Indian patients starting medical weight loss in 2026, a DCGI-approved generic semaglutide pen delivers the same molecule at a fraction of the imported-brand price, which matters because this is a multi-month journey. At ALTRcare, our doctors typically prescribe CDSCO-approved Indian semaglutide, with the full program (medication, delivery, doctor follow-ups and WhatsApp coaching) starting at ₹3,499 a month. Individual results vary, and the right starting point depends on your profile.
Key takeaways
- Ozempic IS semaglutide. Ozempic, Wegovy and Rybelsus are Novo Nordisk brand names for the same molecule.
- Wegovy is the weight-management version (up to 2.4 mg); Ozempic carries the diabetes approval (up to 2 mg).
- Since March 2026, DCGI-approved Indian generics like Semasize offer the same molecule from about ₹1,800 a month.
- Every form is prescription-only. The brand is a pricing and device decision; the medicine is the same.
Not sure which semaglutide option fits you?
Take the 2-minute assessment and an ALTRcare doctor will review your profile and recommend the right starting point.
Frequently asked questions
Is Ozempic the same as semaglutide?
Yes. Semaglutide is the medicine; Ozempic is Novo Nordisk's brand name for it. Wegovy, Rybelsus and Indian generics like Semasize contain the same molecule.
Is generic semaglutide as good as Ozempic?
DCGI-approved Indian generics contain the same molecule and were required to complete Phase 3 trials in Indian patients before approval. Alkem's SIZE-DM trial demonstrated non-inferiority against the Novo Nordisk original. Devices and dose formats vary by brand.
Can I get Ozempic for weight loss in India?
Ozempic carries a diabetes approval and its Indian availability is limited. For weight management, doctors in India prescribe Wegovy or, far more commonly in 2026, DCGI-approved generic semaglutide at a much lower cost. All options need a prescription.
Is semaglutide available without a prescription?
No. Every legitimate form of semaglutide in India is prescription-only. Sellers offering it without a prescription are a safety red flag.
Ready to take the next step?
Take the free 2-minute eligibility assessment. A doctor reviews it before anything is prescribed — no obligation.
This article is for general educational purposes and is not a substitute for personalised medical advice. GLP-1 medications are prescription-only and not suitable for everyone. Always consult a qualified doctor before starting, changing, or stopping any treatment.
